Breaking News Instant updates and real-time market news.

XLU

Utilities SPDR

$57.29

-0.16 (-0.28%)

, KNDI

Kandi Technologies

$5.35

-0.09 (-1.65%)

08:45
04/18/19
04/18
08:45
04/18/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Utilities Sector SPDR ETF (XLU) 2.69% +2.19, Kandi Technologies (KNDI) 17.47% +1.59, Coty (COTY) 2.43% +0.51, ProShares Ultra VIX Short Term Futures (UVXY) 5.77% +0.34, KB Home (KBH) 0.98% +0.13, Stitch Fix (SFIX) 1.55% +0.13, CannTrust Holdings (CTST) 18.58% +0.05, iShares Nasdaq Biotechnology Index Fund (IBB) 1.16% +0.01, Chesapeake (CHK) 0.47% +0.01, and Seabridge Gold (SA) 2.81% +0.01.

XLU

Utilities SPDR

$57.29

-0.16 (-0.28%)

KNDI

Kandi Technologies

$5.35

-0.09 (-1.65%)

COTY

Coty

$11.25

0.07 (0.63%)

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$32.30

0.18 (0.56%)

KBH

KB Home

$25.57

0.31 (1.23%)

SFIX

Stitch Fix

$25.20

-1.14 (-4.33%)

CTST

CannTrust

$7.27

0.43 (6.29%)

IBB

iShares Nasdaq Biotechnology Index

$105.09

-4.37 (-3.99%)

CHK

Chesapeake

$3.07

-0.045 (-1.45%)

SA

Seabridge Gold

$11.15

-0.01 (-0.09%)

  • 17

    May

XLU Utilities SPDR
$57.29

-0.16 (-0.28%)

KNDI Kandi Technologies
$5.35

-0.09 (-1.65%)

COTY Coty
$11.25

0.07 (0.63%)

04/17/19
STFL
04/17/19
DOWNGRADE
STFL
Hold
Coty downgraded to Hold from Buy at Stifel
04/16/19
04/16/19
UPGRADE
Target $15

Buy
e.l.f. Beauty upgraded to Buy at DA Davidson on increased shelf space presence
As previously reported, DA Davidson analyst Linda Bolton Weiser upgraded e.l.f. Beauty to Buy from Hold and raised her price target to $15 from $7. The analyst cites the findings of her proprietary store checks suggesting that the company products have seen a 17% increase in shelf space at Target (TGT), overtaking Coty's (COTY) Covergirl brand, while its Q1 sales "inflected from down high-single digits" in Q4 to low-single digits. Weiser believes that her FY20 sales forecast of a 2% decline may be conservative based on these findings.
04/02/19
SBSH
04/02/19
DOWNGRADE
Target $12
SBSH
Neutral
Coty downgraded to Neutral from Buy at Citi
Citi analyst Wendy Nicholson downgraded Coty to Neutral from Buy and lowered her price target for the shares to $12 from $13. The analyst cites valuation for the downgrade following the stock's year-to-date rally.
04/17/19
04/17/19
DOWNGRADE
Target $12

Hold
Coty downgraded to Hold from Buy at Stifel
As previously reported, Stifel analyst Mark Astrachan downgraded Coty to Hold and kept his price target at $12, saying the stock is faced with an "increased risk of sustaining modest sales growth and weakening investor confidence in the business turnaround." While the analyst anticipates "only minor residual impact" from supply disruptions on Q3 results, he sees the outlook for Consumer Beauty remaining muted and also points to the company's debt levels and free cash flows limiting its strategic optionality.
UVXY ProShares Trust Ultra VIX Short Term Futures ETF
$32.30

0.18 (0.56%)

KBH KB Home
$25.57

0.31 (1.23%)

02/28/19
EVER
02/28/19
DOWNGRADE
Target $24
EVER
In Line
KB Home downgraded to In Line on valuation at Evercore ISI
As previously reported, Evercore ISI downgraded KB Home to In Line from Outperform and maintained a $24 price target. Analyst Stephen Kim said the "easy money" has been made since he upgraded the homebuilders back in October with the group up over 25%. His checks also indicate the Spring Selling season is off to a slow start and looking further out, Kim sees headline risk from leadership changes at the Federal Housing Administration and the Federal Housing Fiance Administration that could lead to a slowdown in high-DTI agency lending.
03/27/19
BTIG
03/27/19
NO CHANGE
Target $17
BTIG
Sell
KB Home earnings beat driven in part by lower tax rate, says BTIG
BTIG analyst Carl Reichardt kept his Sell rating and $17 price target on KB Home after its Q1 results, saying the earnings beat was driven by lower tax rates and better gross margins. The analyst noted that the company's 4% order decline was better than his expected 13% slide, but expressed concerns with Q2 operating margin outlook coming 170bps below his prior forecast. Reichardt further warns that the below average growth for KB Home is not priced in at current levels and attributes the sequential improvement in demand to incentives, which should result in "weaker operating margin in the out quarters".
04/10/19
JPMS
04/10/19
UPGRADE
Target $23
JPMS
Neutral
KB Home upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Michael Rehaut upgraded KB Home to Neutral from Underweight and raised his price target for the shares to $23 from $20.50. The ongoing shift towards smaller-sized first-time product and double-digit community count growth should drive "above average fundamentals" in fiscal 2019 for KB Home, Rehaut tells investors in a research note. Further, the analyst believes believe KB's "healthy relative valuation is reasonable."
04/10/19
04/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. First Solar (FSLR) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Brian Lee citing his view on two potential company-specific catalysts. 2. Disney (DIS) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying with tomorrow's investor day, two Star Wars-themed lands opening in the domestic parks this summer, the launch of streaming service Disney+ before year-end, and a potential re-start of the buyback program within 12 months, Disney shares now have catalysts to go along with downside protection. 3. Under Armour (UA, UAA) assumed with a Buy from Neutral at Citi with analyst Paul Lejuez saying Under Armour is "growing up" with a renewed focus on driving profitability and return on invested capital. 4. KB Home (KBH) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the ongoing shift towards smaller-sized first-time product and double-digit community count growth should drive "above average fundamentals" in fiscal 2019 for KB Home. 5. Nordstrom (JWN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Edward Yruma saying recent meetings with co-CEO Erik Nordstrom and CFO Anne Bramman affirm that the company is prepared to transition its asset base as e-commerce continues to grow. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SFIX Stitch Fix
$25.20

-1.14 (-4.33%)

03/12/19
WELS
03/12/19
NO CHANGE
Target $30
WELS
Market Perform
Stitch Fix price target raised to $30 from $22 at Wells Fargo
Wells Fargo analyst Ike Boruchow raised his price target for Stitch Fix to $30 from $22 after a "very impressive" Q2, with strength across the P&L for the quarter itself, as well as a bullish outlook for the second half of the year and beyond. The analyst reiterates a Market Perform rating on the shares.
03/12/19
RHCO
03/12/19
NO CHANGE
Target $43
RHCO
Buy
Stitch Fix price target raised to $43 from $40 at SunTrust
SunTrust analyst Youssef Squali raised his price target on Stitch Fix to $43 and kept his Buy rating after its "solid" Q2 results and "even better" guidance for the second half of 2019. The analyst notes the company's stronger demand and continued improvement in customer retention/engagement countering a popular short thesis and believes that the guidance raise demonstrates that its positive momentum can continue. Squali points to the short interest on Stitch Fix at 28% of float that is likely to drive the shares higher over the near term after the results, but believes that long-term stock appreciation can also be generated by the "sustainable" revenue growth and improving margins.
03/12/19
LEHM
03/12/19
NO CHANGE
Target $32
LEHM
Equal Weight
Stitch Fix price target raised to $32 from $26 at Barclays
Barclays analyst Ross Sandler raised his price target for Stitch Fix to $32 after the company reported revenue and EBITDA that were 1.5% and $8M above consensus and guided 2019 higher. Inventory management is the key constraint to Stitch Fix's business, and it appears that the company has reached a new level of efficiency above and beyond any negative mix shift to Men's/Kids, Sandler tells investors in a post-earnings research note. Looking forward, the company is lapping the gross margin improvements realized in 2018, which will likely make significant bottom line outperformances harder, adds the analyst. He remains upbeat on Stitch Fix's fundamentals but keeps an Equal Weight rating on the name.
03/12/19
RBCM
03/12/19
NO CHANGE
Target $52
RBCM
Outperform
Stitch Fix price target raised to $52 from $39 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Stitch Fix to $52 and kept his Outperform rating after its "beat and raise" Q2 results. The analyst notes that the quarter showed "positive trends" of accelerating revenue growth and expanded EBITDA margins, along with higher than expected active clients and rising annual revenue per client, even though its net additions were down.
CTST CannTrust
$7.27

0.43 (6.29%)

IBB iShares Nasdaq Biotechnology Index
$105.09

-4.37 (-3.99%)

CHK Chesapeake
$3.07

-0.045 (-1.45%)

04/12/19
GSCO
04/12/19
DOWNGRADE
Target $2.5
GSCO
Sell
Chesapeake downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Brian Singer downgraded Chesapeake Energy to Sell from Neutral and lowered his price target for the shares to $2.50 from $2.75.
04/12/19
GSCO
04/12/19
NO CHANGE
GSCO
Goldman downgrades California Resources, Chesapeake to Sell, upgrades Murphy
Within the Exploration and Production space, Goldman Sachs analyst Brian Singer recommends selling stocks where the valuation post recent rallies "appears at odds" with the company's competitive positioning. With that in mind, Singer downgraded both California Resources (CRC) and Chesapeake Energy (CHK) to Sell from Neutral. California Resources has a low decline rate and competitive supply cost but unfavorable debt cost that does not warrant the extent of its current valuation premium, says the analyst. For Chesapeake, Singer sees less favorable supply cost and corporate returns. The analyst also upgraded Murphy Oil (MUR) to Neutral from Sell. He believes the stock's current valuation appears more in line with its competitive positioning. Singer recommends buying "low cost oil suppliers" Encana (ECA), Parsley Energy (PE), Pioneer Natural (PXD) and EOG Resources (EOG) and Chevron (CVX).
04/12/19
04/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sell at New Street. 2. Chesapeake (CHK) downgraded to Sell from Neutral at Goldman Sachs. 3. Grainger (GWW) downgraded to Underperform at Gordon Haskett with analyst John Inch citing his view of the risk that Grainger's U.S. sales significantly decelerate, driven by his analysis of web data. 4. LogMeln (LOGM) downgraded to Underweight from Overweight at Barclays with analyst Raimo Lenschow saying the core LogMeln offering around the Gravity platform is at the end of its growth trajectory, as the impact of pricing is weakening. 5. Crown Castle (CCI) downgraded to Neutral from Buy at Guggenheim with analyst Robert Gutman saying secular strength is now reflected in valuation and raised his price target to $127 from $120. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
IMPC
01/10/19
NO CHANGE
Target $3
IMPC
In-Line
Chesapeake price target lowered to $3 from $5 at Imperial Capital
Imperial Capital analyst Jason Wangler lowered his price target for Chesapeake Energy to $3 and keeps an In-Line rating on the shares following the company's operational update. Chesapeake's Q4 production was strong on the back of active/successful Powder River Basin and Eagle Ford operations, Wangler tells investors in a research note. Further, he says the company's 2019 activity and efficiency is expected to reduce capital expenditures.
SA Seabridge Gold
$11.15

-0.01 (-0.09%)

07/13/18
ROTH
07/13/18
INITIATION
Target $17
ROTH
Buy
Seabridge Gold initiated with a Buy at Roth Capital
Roth Capital analyst Joe Reagor initiated Seabridge Gold with a Buy rating and $17 price target citing what he views as its "unique combination" of gold price leverage and near-term catalysts. Reagor also believes the company is on the cusp of attracting a strategic partner for its flagship KSM project, he tells investors.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/11/19
12/11
14:17
12/11/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/11/19
12/11
14:16
12/11/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$18.85

0.17 (0.91%)

14:15
12/11/19
12/11
14:15
12/11/19
14:15
Options
Mylan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
12/11/19
12/11
14:15
12/11/19
14:15
General news
FOMC left policy unchanged, as expected »

FOMC left policy…

14:15
12/11/19
12/11
14:15
12/11/19
14:15
General news
Breaking General news story  »

Fed Chair Press…

14:15
12/11/19
12/11
14:15
12/11/19
14:15
General news
Breaking General news story  »

Fed Chair Press…

DIS

Disney

$146.98

0.86 (0.59%)

14:12
12/11/19
12/11
14:12
12/11/19
14:12
Periodicals
Disneyland workers sue company over wages, NY Post says »

Disneyland workers have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:08
12/11/19
12/11
14:08
12/11/19
14:08
General news
Treasury Budget data reported »

November Treasury Budget…

YETI

Yeti

$32.29

1.66 (5.42%)

14:05
12/11/19
12/11
14:05
12/11/19
14:05
Options
YETI Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.70

0.15 (0.05%)

14:03
12/11/19
12/11
14:03
12/11/19
14:03
General news
Fed says economic activity rising at 'moderate rate' »

The Federal Reserve said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.70

0.15 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:02
12/11/19
12/11
14:02
12/11/19
14:02
General news
FOMC Meeting Announcement Federal Funds Rate data reported »

FOMC Meeting Announcement…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.65

0.1 (0.03%)

14:01
12/11/19
12/11
14:01
12/11/19
14:01
Periodicals
Fed keeps rates unchanged, says current policy stance 'appropriate' »

The Federal Reserve said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.65

0.1 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$313.65

0.1 (0.03%)

, SPX

S&P 500

$0.00

(0.00%)

14:01
12/11/19
12/11
14:01
12/11/19
14:01
General news
Fed projections point to 1.6% Federal funds rate to end 2020 »

The economic projections…

SPY

SPDR S&P 500 ETF Trust

$313.65

0.1 (0.03%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIA

Saia

$93.02

1.6 (1.75%)

14:01
12/11/19
12/11
14:01
12/11/19
14:01
Conference/Events
Saia management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 13

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.66

0.11 (0.04%)

14:00
12/11/19
12/11
14:00
12/11/19
14:00
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Federal Reserve keeps…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.66

0.11 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$212.00

-3.84 (-1.78%)

13:54
12/11/19
12/11
13:54
12/11/19
13:54
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 25

    Feb

EVH

Evolent Health

$8.60

-0.39 (-4.34%)

, ANTM

Anthem

$280.75

-2.84 (-1.00%)

13:48
12/11/19
12/11
13:48
12/11/19
13:48
Periodicals
Outgoing Kentucky administration upholds 'snub' of Evolent partner, LCJ says »

The finance secretary of…

EVH

Evolent Health

$8.60

-0.39 (-4.34%)

ANTM

Anthem

$280.75

-2.84 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAAS

Pan American Silver

$20.30

0.53 (2.68%)

13:45
12/11/19
12/11
13:45
12/11/19
13:45
Options
Pan American Silver call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
12/11/19
12/11
13:45
12/11/19
13:45
General news
Treasury Budget to be reported at 14:00 »

November Treasury Budget…

13:45
12/11/19
12/11
13:45
12/11/19
13:45
General news
FOMC Meeting Announcement Federal Funds Rate to be reported at 14:00 »

FOMC Meeting Announcement…

SBPH

Spring Bank Pharmaceuticals

$3.20

-0.25 (-7.25%)

13:41
12/11/19
12/11
13:41
12/11/19
13:41
Recommendations
Spring Bank Pharmaceuticals analyst commentary  »

Spring Bank to add CASOs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$13.99

-0.155 (-1.10%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Options
CenturyLink call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$34.68

0.39 (1.14%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
Cowen industrial innovation analyst to hold an analyst/industry conference call »

Industrial Innovation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

BIIB

Biogen

$293.60

-3.45 (-1.16%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
SVB Leerink biotech analyst to hold analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLNX

Xilinx

$93.24

1.99 (2.18%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
Xilinx participates in a conference call with Benchmark »

Semiconductor Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

  • 28

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.